Abstract
Background: Gallstone disease (GD) is increasing in the world and has various complications.
Objective: This study aims to examine the relationship between GD and the risk of mortality from cardiovascular disease (CVD) and cancer using a systematic review and meta-analysis approach.
Methods: A comprehensive and systematic search was done in various databases, such as Web of Science (WOS), Scopus, MEDLINE/PubMed, Cochrane, and Embase. The search included studies published from 1980 to December 2023. Heterogeneity was assessed using Chi-square, I2, and forest plots, while publication bias was evaluated through Begg's and Egger's tests. All analyses were performed using Stata 15, with statistical significance set at p <0.05.
Results: A pooled analysis of five studies involving 161,671 participants demonstrated that individuals with GD had a significantly higher risk of mortality from CVD (RR 1.29, 95% CI: 1.11-1.50, p <0.001). Importantly, no evidence of publication bias was found based on the results of Begg's test (p =0.806) and Egger's test (p =0.138). Furthermore, the pooled analysis of seven studies, encompassing a total of 562,625 participants, indicated an increased risk of cancer mortality among individuals with GD (RR 1.45, 95% CI: 1.16-1.82, p <0.001). Similarly, no publication bias was detected through Begg's test (p =0.133) and Egger's test (p =0.089).
Conclusion: In this study, the evidence of a significant association between GD and an elevated risk of mortality from CVD and canceris provided. These findings suggest that implementing targeted interventions for individuals with gallstone disease could reduce mortality rates among these patients.
Graphical Abstract
[1]
Jones, M.W.; Weir, C.B.; Ghassemzadeh, S. Gallstones (Cholelithiasis); StatPearls Publishing: Treasure Island, FL, 2024.
[2]
Unalp-Arida, A.; Ruhl, C.E. Increasing gallstone disease prevalence and associations with gallbladder and biliary tract mortality in the US. Hepatology, 2023, 77(6), 1882-1895.
[http://dx.doi.org/10.1097/HEP.0000000000000264] [PMID: 36631004]
[http://dx.doi.org/10.1097/HEP.0000000000000264] [PMID: 36631004]
[3]
Tanaja, J.; Lopez, R.A.; Meer, J.M. Cholelithiasis; StatPearls Publishing: Treasure Island, FL, 2023.
[4]
Gandhi, D.; Ojili, V.; Nepal, P.; Nagar, A.; Hernandez-Delima, F.J.; Bajaj, D.; Choudhary, G.; Gupta, N.; Sharma, P. A pictorial review of gall stones and its associated complications. Clin. Imaging, 2020, 60(2), 228-236.
[http://dx.doi.org/10.1016/j.clinimag.2019.11.015] [PMID: 31931279]
[http://dx.doi.org/10.1016/j.clinimag.2019.11.015] [PMID: 31931279]
[5]
Mohebi, R.; Chen, C.; Ibrahim, N.E.; McCarthy, C.P.; Gaggin, H.K.; Singer, D.E.; Hyle, E.P.; Wasfy, J.H.; Januzzi, J.L., Jr. Cardiovascular disease projections in the United States Based on the 2020 Census Estimates. J. Am. Coll. Cardiol., 2022, 80(6), 565-578.
[http://dx.doi.org/10.1016/j.jacc.2022.05.033] [PMID: 35926929]
[http://dx.doi.org/10.1016/j.jacc.2022.05.033] [PMID: 35926929]
[6]
Adhikary, D.; Barman, S.; Ranjan, R.; Stone, H. A systematic review of major cardiovascular risk factors: A growing global health concern. Cureus, 2022, 14(10), e30119.
[http://dx.doi.org/10.7759/cureus.30119] [PMID: 36381818]
[http://dx.doi.org/10.7759/cureus.30119] [PMID: 36381818]
[7]
Mendis, S.; Graham, I.; Narula, J. Addressing the global burden of cardiovascular diseases; need for scalable and sustainable frameworks. Glob. Heart, 2022, 17(1), 48.
[http://dx.doi.org/10.5334/gh.1139] [PMID: 36051329]
[http://dx.doi.org/10.5334/gh.1139] [PMID: 36051329]
[8]
Wu, S.; Xu, W.; Guan, C.; Lv, M.; Jiang, S.; Jinhua, Z. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990–2019: An analysis of observational data from a 2019 Global Burden of Disease study. BMJ Open, 2023, 13(5), e069397.
[http://dx.doi.org/10.1136/bmjopen-2022-069397] [PMID: 37173115]
[http://dx.doi.org/10.1136/bmjopen-2022-069397] [PMID: 37173115]
[9]
Magnussen, C.; Ojeda, F.M.; Leong, D.P.; Alegre-Diaz, J.; Amouyel, P.; Aviles-Santa, L.; De Bacquer, D.; Ballantyne, C.M.; Bernabé-Ortiz, A.; Bobak, M.; Brenner, H.; Carrillo-Larco, R.M.; de Lemos, J.; Dobson, A.; Dörr, M.; Donfrancesco, C.; Drygas, W.; Dullaart, R.P.; Engström, G.; Ferrario, M.M.; Ferrières, J.; de Gaetano, G.; Goldbourt, U.; Gonzalez, C.; Grassi, G.; Hodge, A.M.; Hveem, K.; Iacoviello, L.; Ikram, M.K.; Irazola, V.; Jobe, M.; Jousilahti, P.; Kaleebu, P.; Kavousi, M.; Kee, F.; Khalili, D.; Koenig, W.; Kontsevaya, A.; Kuulasmaa, K.; Lackner, K.J.; Leistner, D.M.; Lind, L.; Linneberg, A.; Lorenz, T.; Lyngbakken, M.N.; Malekzadeh, R.; Malyutina, S.; Mathiesen, E.B.; Melander, O.; Metspalu, A.; Miranda, J.J.; Moitry, M.; Mugisha, J.; Nalini, M.; Nambi, V.; Ninomiya, T.; Oppermann, K.; d’Orsi, E.; Pająk, A.; Palmieri, L.; Panagiotakos, D.; Perianayagam, A.; Peters, A.; Poustchi, H.; Prentice, A.M.; Prescott, E.; Risérus, U.; Salomaa, V.; Sans, S.; Sakata, S.; Schöttker, B.; Schutte, A.E.; Sepanlou, S.G.; Sharma, S.K.; Shaw, J.E.; Simons, L.A.; Söderberg, S.; Tamosiunas, A.; Thorand, B.; Tunstall-Pedoe, H.; Twerenbold, R.; Vanuzzo, D.; Veronesi, G.; Waibel, J.; Wannamethee, S.G.; Watanabe, M.; Wild, P.S.; Yao, Y.; Zeng, Y.; Ziegler, A.; Blankenberg, S. Global effect of modifiable risk factors on cardiovascular disease and mortality. N. Engl. J. Med., 2023, 389(14), 1273-1285.
[http://dx.doi.org/10.1056/NEJMoa2206916] [PMID: 37632466]
[http://dx.doi.org/10.1056/NEJMoa2206916] [PMID: 37632466]
[10]
Mattiuzzi, C.; Lippi, G. Current cancer epidemiology. J. Epidemiol. Glob. Health, 2019, 9(4), 217-222.
[http://dx.doi.org/10.2991/jegh.k.191008.001] [PMID: 31854162]
[http://dx.doi.org/10.2991/jegh.k.191008.001] [PMID: 31854162]
[12]
Shabanzadeh, D.M.; Sørensen, L.T.; Jørgensen, T. Gallstone disease and mortality: A cohort study. Int. J. Public Health, 2017, 62(3), 353-360.
[http://dx.doi.org/10.1007/s00038-016-0916-7] [PMID: 27815564]
[http://dx.doi.org/10.1007/s00038-016-0916-7] [PMID: 27815564]
[13]
Zheng, Y.; Xu, M.; Heianza, Y.; Ma, W.; Wang, T.; Sun, D.; Albert, C.M.; Hu, F.B.; Rexrode, K.M.; Manson, J.E.; Qi, L. Gallstone disease and increased risk of mortality: Two large prospective studies in US men and women. J. Gastroenterol. Hepatol., 2018, 33(11), 1925-1931.
[http://dx.doi.org/10.1111/jgh.14264] [PMID: 29671893]
[http://dx.doi.org/10.1111/jgh.14264] [PMID: 29671893]
[14]
Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Symp. Syst. Rev. Beyond Basics, 2011, 7, 1-12.
[15]
Chavez-Tapia, N.C.; Mac Kinney-Novelo, I.; Sifuentes-RenterÍa, S.E.; Torres-Zavala, M.; Castro-Gastelum, G.; Sánchez-Lara, K.; Paulin-Saucedo, C.; Uribe, M.; Méndez-Sánchez, N. Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann. Hepatol., 2012, 11(1), 85-89.
[http://dx.doi.org/10.1016/S1665-2681(19)31490-5] [PMID: 22166565]
[http://dx.doi.org/10.1016/S1665-2681(19)31490-5] [PMID: 22166565]
[16]
Su, W.; Zhu, J.G.; Li, W.P.; Chen, H.; Li, H.W. Gallstone disease and the risk of cardiac mortality in patients with acute coronary syndrome. Front. Cardiovasc. Med., 2022, 9, 1033959.
[http://dx.doi.org/10.3389/fcvm.2022.1033959] [PMID: 36505391]
[http://dx.doi.org/10.3389/fcvm.2022.1033959] [PMID: 36505391]
[17]
Scollay, J.M.; Mullen, R.; McPhillips, G.; Thompson, A.M. Mortality associated with the treatment of gallstone disease: A 10-year contemporary national experience. World J. Surg., 2011, 35(3), 643-647.
[http://dx.doi.org/10.1007/s00268-010-0908-3] [PMID: 21181471]
[http://dx.doi.org/10.1007/s00268-010-0908-3] [PMID: 21181471]
[18]
Kono, S.; Ichimiya, H.; Tokudome, S.; Ikeda, M.; Nakayama, F. Type of gallstones and deaths from stroke and coronary heart disease among cholecystectomized patients. Int. J. Epidemiol., 1988, 17(1), 82-85.
[http://dx.doi.org/10.1093/ije/17.1.82] [PMID: 3384554]
[http://dx.doi.org/10.1093/ije/17.1.82] [PMID: 3384554]
[19]
Barker, D.J.; Gardner, M.J.; Power, C.; Hutt, M.S. Prevalence of gall stones at necropsy in nine British towns: A collaborative study. BMJ, 1979, 2(6202), 1389-1392.
[http://dx.doi.org/10.1136/bmj.2.6202.1389] [PMID: 519474]
[http://dx.doi.org/10.1136/bmj.2.6202.1389] [PMID: 519474]
[20]
Godrey, P.J.; Bates, T.; Harrison, M.; King, M.B.; Padley, N.R. Gall stones and mortality: A study of all gall stone related deaths in a single health district. Gut, 1984, 25(10), 1029-1033.
[http://dx.doi.org/10.1136/gut.25.10.1029] [PMID: 6479677]
[http://dx.doi.org/10.1136/gut.25.10.1029] [PMID: 6479677]
[21]
Grimaldi, C.H.; Nelson, R.G.; Pettitt, D.J.; Sampliner, R.E.; Bennett, P.H.; Knowler, W.C. Increased mortality with gallstone disease: Results of a 20-year population-based survey in Pima Indians. Ann. Intern. Med., 1993, 118(3), 185-190.
[http://dx.doi.org/10.7326/0003-4819-118-3-199302010-00005] [PMID: 8417635]
[http://dx.doi.org/10.7326/0003-4819-118-3-199302010-00005] [PMID: 8417635]
[22]
Ruhl, C.E.; Everhart, J.E. Gallstone disease is associated with increased mortality in the United States. Gastroenterology, 2011, 140(2), 508-516.
[http://dx.doi.org/10.1053/j.gastro.2010.10.060] [PMID: 21075109]
[http://dx.doi.org/10.1053/j.gastro.2010.10.060] [PMID: 21075109]
[23]
Konyn, P.; Alshuwaykh, O.; Dennis, B.B.; Cholankeril, G.; Ahmed, A.; Kim, D. Gallstone disease and its association with nonalcoholic fatty liver disease, all-cause and cause-specific mortality. Clin. Gastroenterol. Hepatol., 2023, 21(4), 940-948.e2.
[http://dx.doi.org/10.1016/j.cgh.2022.04.043] [PMID: 35643414]
[http://dx.doi.org/10.1016/j.cgh.2022.04.043] [PMID: 35643414]
[24]
Schmidt, M.; Småstuen, M.C.; Søndenaa, K. Increased cancer incidence in some gallstone diseases, and equivocal effect of cholecystectomy: A long-term analysis of cancer and mortality. Scand. J. Gastroenterol., 2012, 47(12), 1467-1474.
[http://dx.doi.org/10.3109/00365521.2012.719928] [PMID: 22946484]
[http://dx.doi.org/10.3109/00365521.2012.719928] [PMID: 22946484]
[25]
Ryu, S.; Chang, Y.; Yun, K.E.; Jung, H.S.; Shin, J.H.; Shin, H. Gallstones and the risk of gallbladder cancer mortality: A cohort study. Am. J. Gastroenterol., 2016, 111(10), 1476-1487.
[http://dx.doi.org/10.1038/ajg.2016.345] [PMID: 27575712]
[http://dx.doi.org/10.1038/ajg.2016.345] [PMID: 27575712]
[26]
Fairfield, C.J.; Wigmore, S.J.; Harrison, E.M. Gallstone disease and the risk of cardiovascular disease. Sci. Rep., 2019, 9(1), 5830.
[http://dx.doi.org/10.1038/s41598-019-42327-2] [PMID: 30967586]
[http://dx.doi.org/10.1038/s41598-019-42327-2] [PMID: 30967586]
[27]
Wang, X.; Yu, W.; Li, S.; Xie, L.; He, Y.; Liu, Y.; Li, H.; Jiang, G.; Chen, X.; Bai, X. Gallstone disease and risk of non-communicable diseases incidence and all-cause mortality: Cumulative evidence from longitudinal studies with over 25 million participants. SSRN, 2013.
[http://dx.doi.org/10.2139/ssrn.4561801]
[http://dx.doi.org/10.2139/ssrn.4561801]
[28]
Upala, S.; Sanguankeo, A.; Jaruvongvanich, V. Gallstone disease and the risk of cardiovascular disease: A systematic review and meta-analysis of observational studies. Scand. J. Surg., 2017, 106(1), 21-27.
[http://dx.doi.org/10.1177/1457496916650998] [PMID: 27255283]
[http://dx.doi.org/10.1177/1457496916650998] [PMID: 27255283]
[29]
Völzke, H.; Baumeister, S.E.; Alte, D.; Hoffmann, W.; Schwahn, C.; Simon, P.; John, U.; Lerch, M.M. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion, 2005, 71(2), 97-105.
[http://dx.doi.org/10.1159/000084525] [PMID: 15775677]
[http://dx.doi.org/10.1159/000084525] [PMID: 15775677]
[30]
Almobarak, A.O.; Jervase, A.; Fadl, A.A.; Garelnabi, N.I.A.; Hakem, S.A.; Hussein, T.M.; Ahmad, A.A.A.; Ahmed, I.S.E.; Badi, S.; Ahmed, M.H. The prevalence of diabetes and metabolic syndrome and associated risk factors in Sudanese individuals with gallstones: A cross sectional survey. Transl. Gastroenterol. Hepatol., 2020, 5, 15.
[http://dx.doi.org/10.21037/tgh.2019.10.09] [PMID: 32258518]
[http://dx.doi.org/10.21037/tgh.2019.10.09] [PMID: 32258518]
[31]
Haal, S.; Guman, M.S.S.; Bruin, S.; Schouten, R.; van Veen, R.N.; Fockens, P.; Dijkgraaf, M.G.W.; Hutten, B.A.; Gerdes, V.E.A.; Voermans, R.P. Risk factors for symptomatic gallstone disease and gallstone formation after bariatric surgery. Obes. Surg., 2022, 32(4), 1270-1278.
[http://dx.doi.org/10.1007/s11695-022-05947-8] [PMID: 35143012]
[http://dx.doi.org/10.1007/s11695-022-05947-8] [PMID: 35143012]
[32]
Fan, Y.; Hu, J.; Feng, B.; Wang, W.; Yao, G.; Zhai, J.; Li, X. Increased risk of pancreatic cancer related to gallstones and cholecystectomy. Pancreas, 2016, 45(4), 503-509.
[http://dx.doi.org/10.1097/MPA.0000000000000502] [PMID: 26684857]
[http://dx.doi.org/10.1097/MPA.0000000000000502] [PMID: 26684857]
[33]
Wirth, J.; Giuseppe, R.; Wientzek, A.; Katzke, V.A.; Kloss, M.; Kaaks, R.; Boeing, H.; Weikert, C. Presence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study. Eur. J. Prev. Cardiol., 2015, 22(3), 326-334.
[http://dx.doi.org/10.1177/2047487313512218] [PMID: 24177267]
[http://dx.doi.org/10.1177/2047487313512218] [PMID: 24177267]
[34]
Wang, DQ; Cohen, DE; Carey, MC Biliary lipids and cholesterol gallstone disease. J Lipid Res., 2009, 50(Suppl), S406-11.
[http://dx.doi.org/10.1194/jlr.R800075-JLR200]
[http://dx.doi.org/10.1194/jlr.R800075-JLR200]
[35]
Grigor’eva, I.N.; Romanova, T.I. Gallstone disease and microbiome. Microorganisms, 2020, 8(6), 835.
[http://dx.doi.org/10.3390/microorganisms8060835] [PMID: 32498344]
[http://dx.doi.org/10.3390/microorganisms8060835] [PMID: 32498344]
[36]
Sun, H.; Warren, J.; Yip, J.; Ji, Y.; Hao, S.; Han, W.; Ding, Y. Factors influencing gallstone formation: A review of the literature. Biomolecules, 2022, 12(4), 550.
[http://dx.doi.org/10.3390/biom12040550] [PMID: 35454138]
[http://dx.doi.org/10.3390/biom12040550] [PMID: 35454138]
[37]
Binda, C.; Gibiino, G.; Coluccio, C.; Sbrancia, M.; Dajti, E.; Sinagra, E.; Capurso, G.; Sambri, V.; Cucchetti, A.; Ercolani, G.; Fabbri, C. Biliary diseases from the microbiome perspective: How microorganisms could change the approach to benign and malignant diseases. Microorganisms, 2022, 10(2), 312.
[http://dx.doi.org/10.3390/microorganisms10020312] [PMID: 35208765]
[http://dx.doi.org/10.3390/microorganisms10020312] [PMID: 35208765]
[38]
Miele, L.; Giorgio, V.; Alberelli, M.A.; De Candia, E.; Gasbarrini, A.; Grieco, A. Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk. Curr. Cardiol. Rep., 2015, 17(12), 120.
[http://dx.doi.org/10.1007/s11886-015-0671-z] [PMID: 26497040]
[http://dx.doi.org/10.1007/s11886-015-0671-z] [PMID: 26497040]
[39]
Rawla, P.; Sunkara, T.; Thandra, K.C.; Barsouk, A. Epidemiology of gallbladder cancer. Clin. Exp. Hepatol., 2019, 5(2), 93-102.
[http://dx.doi.org/10.5114/ceh.2019.85166] [PMID: 31501784]
[http://dx.doi.org/10.5114/ceh.2019.85166] [PMID: 31501784]
[40]
Sabbatino, F.; Conti, V.; Liguori, L.; Polcaro, G.; Corbi, G.; Manzo, V.; Tortora, V.; Carlomagno, C.; Vecchione, C.; Filippelli, A.; Pepe, S. Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients. Life (Basel), 2021, 11(2), 105.
[http://dx.doi.org/10.3390/life11020105] [PMID: 33573162]
[http://dx.doi.org/10.3390/life11020105] [PMID: 33573162]
[41]
Di Ciaula, A.; Wang, DQ.; Molina-Molina, E.; Lunardi Baccetto, R.; Calamita, G.; Palmieri, V.O.; Portincasa, P. Bile acids and cancer: Direct and environmental-dependent effects. Ann. Hepatol., 2017, 16(Suppl. 1), s87-s105.
[http://dx.doi.org/10.5604/01.3001.0010.5501]
[http://dx.doi.org/10.5604/01.3001.0010.5501]
[42]
Li, T.; Apte, U. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv. Pharmacol., 2015, 74, 263-302.
[http://dx.doi.org/10.1016/bs.apha.2015.04.003] [PMID: 26233910]
[http://dx.doi.org/10.1016/bs.apha.2015.04.003] [PMID: 26233910]
[43]
Feng, H.Y.; Chen, Y.C. Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective. World J. Gastroenterol., 2016, 22(33), 7463-7477.
[http://dx.doi.org/10.3748/wjg.v22.i33.7463] [PMID: 27672269]
[http://dx.doi.org/10.3748/wjg.v22.i33.7463] [PMID: 27672269]
[44]
Luo, X.; Yang, W.; Joshi, A.D.; Wu, K.; Simon, T.G.; Yuan, C.; Jin, L.; Long, L.; Kim, M.N.; Lo, C.H.; Liu, X.; Abrams, T.A.; Wolpin, B.M.; Chan, A.T.; Giovannucci, E.L.; Zhang, X. Gallstones and risk of cancers of the liver, biliary tract and pancreas: A prospective study within two U.S. cohorts. Br. J. Cancer, 2022, 127(6), 1069-1075.
[http://dx.doi.org/10.1038/s41416-022-01877-5] [PMID: 35715632]
[http://dx.doi.org/10.1038/s41416-022-01877-5] [PMID: 35715632]
[45]
Sun, N.; Wang, X.; Wei, J. Gallstones, cholecystectomy and the risk of pancreatic cancer: An updated systematic review and meta-analysis of cohort studies. Eur. J. Gastroenterol. Hepatol., 2023, 35(12), 1313-1323.
[http://dx.doi.org/10.1097/MEG.0000000000002652] [PMID: 37823406]
[http://dx.doi.org/10.1097/MEG.0000000000002652] [PMID: 37823406]
[46]
Pang, Y.; Lv, J.; Kartsonaki, C.; Guo, Y.; Yu, C.; Chen, Y.; Yang, L.; Bian, Z.; Millwood, I.Y.; Walters, R.G.; Li, X.; Zou, J.; Holmes, M.V.; Chen, J.; Chen, Z.; Li, L. Causal effects of gallstone disease on risk of gastrointestinal cancer in Chinese. Br. J. Cancer, 2021, 124(11), 1864-1872.
[http://dx.doi.org/10.1038/s41416-021-01325-w] [PMID: 33772150]
[http://dx.doi.org/10.1038/s41416-021-01325-w] [PMID: 33772150]
[47]
Huang, D.; Joo, H.; Song, N.; Cho, S.; Kim, W.; Shin, A. Association between gallstones and the risk of biliary tract cancer: A systematic review and meta-analysis. Epidemiol. Health, 2021, 43, e2021011.
[http://dx.doi.org/10.4178/epih.e2021011] [PMID: 33541011]
[http://dx.doi.org/10.4178/epih.e2021011] [PMID: 33541011]
[48]
Stinton, L.M.; Shaffer, E.A. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver, 2012, 6(2), 172-187.
[http://dx.doi.org/10.5009/gnl.2012.6.2.172] [PMID: 22570746]
[http://dx.doi.org/10.5009/gnl.2012.6.2.172] [PMID: 22570746]
